CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Vera Juan Director | Sale | −700 | $39.53 | $28K | 2,370,910 |
| 2021-03-01 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −4,332 | $38.62 | $167K | 489,830 |
| 2021-03-01 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,600 | $39.21 | $63K | 488,230 |
| 2021-03-01 | Miller Edward General Counsel | Sale | −3,800 | $38.58 | $147K | 195,011 |
| 2021-03-01 | Miller Edward General Counsel | Sale | −2,200 | $39.14 | $86K | 192,811 |
| 2021-03-01 | Leen Ann M. Chief Scientific Officer | Sale | −6,359 | $38.46 | $245K | 2,465,326 |
| 2021-03-01 | Leen Ann M. Chief Scientific Officer | Sale | −3,159 | $39.18 | $124K | 2,462,167 |
| 2021-03-01 | Brenner Malcolm Director | Sale | −12,825 | $38.39 | $492K | 955,794 |
| 2021-03-01 | Brenner Malcolm Director | Sale | −8,869 | $39.00 | $346K | 946,925 |
| 2021-02-23 | Vera Juan Director | Sale | −1,125 | $38.33 | $43K | 2,411,489 |
| 2021-02-23 | Vera Juan Director | Sale | −4,825 | $39.11 | $189K | 2,406,664 |
| 2021-02-23 | Vera Juan Director | Sale | −2,300 | $40.13 | $92K | 2,404,364 |
| 2021-02-23 | Vera Juan Director | Sale | −600 | $40.97 | $25K | 2,403,764 |
| 2021-02-23 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,418 | $39.18 | $56K | 494,862 |
| 2021-02-23 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −700 | $40.32 | $28K | 494,162 |
| 2021-02-23 | Leen Ann M. Chief Scientific Officer | Sale | −1,492 | $38.83 | $58K | 2,474,392 |
| 2021-02-23 | Leen Ann M. Chief Scientific Officer | Sale | −1,907 | $39.59 | $75K | 2,472,485 |
| 2021-02-23 | Leen Ann M. Chief Scientific Officer | Sale | −800 | $40.56 | $32K | 2,471,685 |
| 2021-02-23 | Brenner Malcolm Director | Sale | −2,800 | $38.75 | $108K | 974,308 |
| 2021-02-23 | Brenner Malcolm Director | Sale | −3,688 | $39.46 | $146K | 970,620 |
Page 21 of 27 · 527 trades